Cellectis (FRA:ZVAA) FFO


FRA:ZVAA Cellectis SA FRA:ZVAA
64 GF Score
Price €2.54
GF Value €3.05
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Cellectis FFO?

FFO (Funds from operations) only applies to REITs.

FRA:ZVAA
64GF Score
Cellectis SA FRA:ZVAA
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Cellectis (FRA:ZVAA) Overvalued in 2026?

Based on GuruFocus' analysis, Cellectis stock appears to be undervalued. The current stock price of €2.54 is trading 16.7% below its estimated GF Value™ of €3.05. GuruFocus considers Cellectis to be Modestly Undervalued.

Key valuation signals for FRA:ZVAA:

  • FFO:
  • GF Value™: €3.05 vs. price of €2.54 (16.7% below fair value)
  • GF Score™: 64/100 with 4 warning signs

No single metric tells the full story. See the FRA:ZVAA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cellectis Business Description

Address 8, rue de la Croix Jarry, Paris, FRA, 75013
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
64GF Score

Get the complete analysis for FRA:ZVAA

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.54
Price
€3.05
GF Value